Citigroup’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.21M Buy
43,523
+4,000
+10% +$410K ﹤0.01% 2098
2025
Q4
$4.19M Sell
39,523
-14,079
-26% -$1.63M ﹤0.01% 2148
2025
Q3
$6.81M Buy
53,602
+5,590
+12% +$665K ﹤0.01% 1772
2025
Q2
$5.89M Sell
48,012
-20,613
-30% -$2.35M ﹤0.01% 1755
2025
Q1
$6.95M Buy
68,625
+18,518
+37% +$1.81M ﹤0.01% 1634
2024
Q4
$4.63M Buy
50,107
+17,158
+52% +$1.68M ﹤0.01% 2043
2024
Q3
$3.18M Buy
32,949
+10,172
+45% +$914K ﹤0.01% 2250
2024
Q2
$1.95M Buy
22,777
+1,801
+9% +$151K ﹤0.01% 2369
2024
Q1
$1.73M Buy
20,976
+5,933
+39% +$435K ﹤0.01% 2555
2023
Q4
$1M Buy
15,043
+3,223
+27% +$209K ﹤0.01% 2817
2023
Q3
$794K Sell
11,820
-3,894
-25% -$268K ﹤0.01% 2694
2023
Q2
$1.06M Sell
15,714
-2,121
-12% -$133K ﹤0.01% 2800
2023
Q1
$965K Sell
17,835
-933
-5% -$54.3K ﹤0.01% 2585
2022
Q4
$1.12M Sell
18,768
-6,011
-24% -$327K ﹤0.01% 2515
2022
Q3
$1.12M Buy
24,779
+9,147
+59% +$458K ﹤0.01% 2625
2022
Q2
$697K Sell
15,632
-3,398
-18% -$174K ﹤0.01% 2969
2022
Q1
$1.08M Sell
19,030
-2,172
-10% -$113K ﹤0.01% 2892
2021
Q4
$1.1M Buy
21,202
+2,630
+14% +$136K ﹤0.01% 3147
2021
Q3
$1.11M Sell
18,572
-14,935
-45% -$940K ﹤0.01% 3007
2021
Q2
$2.08M Buy
33,507
+13,249
+65% +$883K ﹤0.01% 2637
2021
Q1
$1.32M Sell
20,258
-808
-4% -$52.7K ﹤0.01% 2773
2020
Q4
$1.39M Buy
21,066
+1,781
+9% +$105K ﹤0.01% 3225
2020
Q3
$996K Sell
19,285
-22,652
-54% -$1.16M ﹤0.01% 3278
2020
Q2
$2.07M Sell
41,937
-37,214
-47% -$2.01M ﹤0.01% 2774
2020
Q1
$4.03M Buy
79,151
+16,370
+26% +$944K ﹤0.01% 1855
2019
Q4
$3.46M Sell
62,781
-80,589
-56% -$4.37M ﹤0.01% 2372
2019
Q3
$7.22M Sell
143,370
-4,346
-3% -$218K 0.01% 1635
2019
Q2
$7.45M Sell
147,716
-14,637
-9% -$710K 0.01% 1624
2019
Q1
$7.54M Buy
162,353
+7,962
+5% +$403K 0.01% 1460
2018
Q4
$7.58M Buy
154,391
+68,476
+80% +$3.89M 0.01% 1474
2018
Q3
$5.33M Buy
85,915
+7,080
+9% +$431K ﹤0.01% 1806
2018
Q2
$4.25M Buy
78,835
+78,061
+10,085% +$3.9M ﹤0.01% 1996
2018
Q1
$35K Sell
774
-445
-37% -$19.1K ﹤0.01% 6405
2017
Q4
$48K Sell
1,219
-326
-21% -$12.4K ﹤0.01% 6209
2017
Q3
$57K Buy
1,545
+703
+83% +$25K ﹤0.01% 5923
2017
Q2
$32K Buy
842
+188
+29% +$6.88K ﹤0.01% 6054
2017
Q1
$22K Sell
654
-63,136
-99% -$2.07M ﹤0.01% 6205
2016
Q4
$2.09M Buy
63,790
+63,522
+23,702% +$2.06M ﹤0.01% 2891
2016
Q3
$8K Sell
268
-9,051
-97% -$293K ﹤0.01% 6619
2016
Q2
$287K Sell
9,319
-76,082
-89% -$2.38M ﹤0.01% 4169
2016
Q1
$2.56M Buy
85,401
+84,970
+19,715% +$2.35M ﹤0.01% 2212
2015
Q4
$12K Sell
431
-17,878
-98% -$509K ﹤0.01% 6733
2015
Q3
$559K Buy
18,309
+13,328
+268% +$464K ﹤0.01% 3642
2015
Q2
$182K Sell
4,981
-6,746
-58% -$241K ﹤0.01% 4504
2015
Q1
$414K Sell
11,727
-18,652
-61% -$638K ﹤0.01% 3929
2014
Q4
$929K Buy
30,379
+26,125
+614% +$815K ﹤0.01% 3219
2014
Q3
$125K Buy
4,254
+2,885
+211% +$87.9K ﹤0.01% 4578
2014
Q2
$39K Sell
1,369
-35,606
-96% -$993K ﹤0.01% 5327
2014
Q1
$1.06M Sell
36,975
-11,457
-24% -$298K ﹤0.01% 2832
2013
Q4
$1.28M Buy
48,432
+31,245
+182% +$869K ﹤0.01% 2957
2013
Q3
$471K Sell
17,187
-6,529
-28% -$168K ﹤0.01% 3476
2013
Q2
$543K Buy
+23,716
New +$536K ﹤0.01% 3417

Other funds holding EHC

Citigroup's EHC Position: Q1 2026 in Review

Citigroup increased its Encompass Health (EHC) stake by 10% in Q1 2026, buying an estimated $410K and bringing the position to 43,523 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Citigroup first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.58M in Q4 2018. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Citigroup held 43,523 shares of Encompass Health worth $4.21M as of Q1 2026.
  • Citigroup bought 4,000 Encompass Health shares in Q1 2026, an estimated $410K.
  • Encompass Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2098 holding.
  • Citigroup first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Encompass Health position peaked at $7.58M in Q4 2018.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.